BOK FINANCIAL CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BOK FINANCIAL CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $577.99M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $523.57M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $530.75M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $520.27M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $618.12M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $435.03M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $500.76M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $445.65M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $334.64M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $232.67M | Mar 1, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $739.62M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $1.43B | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $66.18M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $5.12B | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | ($3.69B) | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | ($416.26M) | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | ($473.68M) | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | ($552.01M) | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $214.93M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | ($91.95M) | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $52.24B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $49.69B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $49.82B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $47.79B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $50.25B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $46.67B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $42.17B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $38.02B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $32.27B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $32.77B | Feb 27, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $46.32B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $44.13B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $44.68B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $43.10B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $44.88B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $41.38B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $37.31B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $33.58B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $28.75B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $29.47B | Feb 27, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.92B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $5.55B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $5.14B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $4.68B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $5.36B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $5.27B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $4.86B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $4.43B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $3.50B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $3.27B | Feb 27, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.04B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $1.04B | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $1.04B | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $1.04B | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $1.04B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $1.05B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $1.05B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $1.05B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $447.43M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $448.90M | Mar 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.02B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $5.59B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $5.21B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $4.82B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $4.45B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $3.97B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $3.73B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $3.37B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $3.05B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $2.82B | Feb 27, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $2.84B | Feb 23, 2022 |
| FY2021 | Dec 31, 2020 | $1.18B | Feb 23, 2022 |
| FY2021 | Dec 31, 2019 | $1.26B | Feb 23, 2022 |
| FY2021 | Dec 31, 2018 | $1.14B | Feb 23, 2022 |
| FY2020 | Dec 31, 2017 | $2.32B | Feb 24, 2021 |
| FY2019 | Dec 31, 2016 | $2.54B | Feb 27, 2020 |
| FY2018 | Dec 31, 2015 | $2.64B | Mar 1, 2019 |
| FY2017 | Dec 31, 2014 | $2.48B | Feb 27, 2018 |
| FY2016 | Dec 31, 2013 | $1.09B | Feb 28, 2017 |
| FY2015 | Dec 31, 2012 | $1.29B | Feb 29, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.63B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $4.45B | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $8.96B | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $7.14B | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $2.49B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $3.82B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $8.62B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $7.42B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $5.85B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $5.72B | Mar 1, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 8 | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 8 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 7 | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 8 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | 6 | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | 7 | Feb 23, 2022 |
| FY2018 | Dec 31, 2018 | 1 | Mar 1, 2019 |
| FY2018 | Dec 31, 2017 | 1 | Mar 1, 2019 |
| FY2018 | Dec 31, 2016 | 3 | Mar 1, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 8 | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 8 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 7 | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 8 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | 6 | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | 7 | Feb 23, 2022 |
| FY2018 | Dec 31, 2018 | 1 | Mar 1, 2019 |
| FY2018 | Dec 31, 2017 | 1 | Mar 1, 2019 |
| FY2018 | Dec 31, 2016 | 3 | Mar 1, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 60.62M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 64.12M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | 76.59M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | 76.42M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | 76.25M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | 76.00M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | 75.76M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | 75.71M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 75.15M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 74.99M | Feb 27, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $147.50M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $142.98M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $143.40M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $143.80M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $144.11M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $144.44M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $143.50M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $127.19M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $116.04M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $113.46M | Mar 1, 2019 |